Deep vein thrombosis: Pathogenesis, diagnosis and therapy. What's proven? What's uncertain?;Tiefe beinvenenthrombose: Pathogenese, diagnostik und therapie. Was ist gesichert? Welche fragen bleiben offen?

Phlebologie

Volumn 34, Issue 1, 2005, Pages 5-14

  Breddin, H K ^a  

^a NONE   (Germany)

Author keywords

Deep vein thrombosis

Indexed keywords

ANTIVITAMIN K; D DIMER; LOW MOLECULAR WEIGHT HEPARIN;

BLOOD FLOW; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; ECHOGRAPHY; HEMOSTASIS; HUMAN; LEG COMPRESSION; PATHOGENESIS; PHLEBOGRAPHY; REVIEW; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VEIN DILATATION;

EID: 14944342206     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621467     Document Type: Review

References (55)

1. Alhenc-Gelas M, Nicaud V, Gandrille S et al. The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb Haemost 1999; 81: 193-7
2. Bergqvist D, Jendteg S, Johansen L et al. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med 1997, 126: 454-7.
3. Blättler W, Gerlach HE, Partsch H et al. Leitlinien zur Diagnostik und Therapie der tiefen Bein- und Beckenvenenthrombose. Phlebologie 2003; 32: 257-63.
4. Brandjes DP, Buller HR, Heijboer H et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997, 349: 759-62.
5. Breddin HK, Hach-Wunderle V, Nakov R et al. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001, 344: 626-31.
6. Breddin HK, Kadziola Z, Scully M et al. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis. Thromb Haemost 2003; 89: 272-7.
7. Breddin HK. Thrombosis and Virchow's trias: what is established? Semin Thromb Hemost 1989; 15: 237-9.
8. Büller HP, Angelli G, Hull RD et al. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and thrombolytic therapy. Chest 2004, 126 (Suppl): 401S-8.
9. Comerota AJ, Stewart GJ, Alburger PD et al. Operative venodilation. A previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery 1989; 106: 301-9.
10. Comerota AJ. Operative venous dilatation and its relationship to postoperative deep vein thrombosis. In: Bergquist D, Comerota AJ, Nicolaides AN et al. (eds). Prevention of Venous Thromboembolism. London: MED-ORION 1994: 31-8.
11. Cushman M, Bhushan F, Bovill E et al. Plasma resistance to activated protein C in venous and arterial thrombosis. Thromb Haemost 1994; 72: 647.
12. Dahl OE, Andreassen G, Aspelin T et al. Prolonged thromboprophylaxis followed hip replacement surgery. Results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin®). Thromb Haemost 1997; 77: 26-31.
13. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anti-coagulant response to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
14. Den Heijer M, Rosendaal FR, Blom HJ et al. Hyperhomocysteinaemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998; 80: 874-7.
15. Eberth CJ, Schimmelbusch C. Die Thrombose nach Versuchen und Leichenbefunden. Stuttgart: Enke 1888.
16. Eichinger S, Minar E, Hirschl M et al. The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with G20210A transition in the prothrombin gene. Thromb Haemost 1999; 81: 14-7.
17. Elias A et al. A single complete ultrasound investigation of the venous network for the diagnostic management of patients with a clinically suspected first episode of deep venous thrombosis of the lower limb. Thromb Haemost 2003; 89: 221.
18. Fischer T, Hähnel A, Schlehahn F et al. Verdacht auf tiefe Beinenvenenthrombose. Diagnostisches Vorgehen an der Schnittstelle zwischen Hausarzt und phlebologischer Schwerpunktpraxis. Phlebologie 2004; 33: 47-52.
19. Gerlach HE, Blättler W. Kontrollierte Einführung der ambulanten Behandlung der akuten tiefen Beinvenenthrombose. Machbarkeitsstudie an 827 Patienten. Phlebologie 2002; 31: 77-84.
20. Hach W. Die Geschichte der venösen Thrombose. Phlebologie 2002; 31: 56-62.
21. Hach-Wunderle V, Scharrer I. Prävalenz des hereditären Mangels an Antithrombin III, Protein C und Protein S. Dtsch Med Wschr 1993; 118: 187-90.
22. Huisman MV1 Büller HR, Cate JW ten et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest 1989; 95: 498-502.
23. Hynes RO. The complexity of platelet adhesion to extracellular matrices. Thromb Haemost 1991: 66: 40.
24. Kahn SR, Solymoss S, Lamping DL et al. Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. J Gen Intern Med 2000, 15: 425-29.
25. Kakkar VV, Cohen AT, Edmonson RA et al. Low molecular weight heparin versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341: 259-65.
26. Kakkar VV, Hoppenstead DA, Fareed J et al. Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis. Blood 2002; 99: 1965-70.
27. Kierkegaard A. Incidence of acute deep vein thrombosis in two districts. A phlebographic study. Acta Chir Scand 1980; 146: 267-9.
28. Kirchmaier CM, Wolf H, Schäfer H et al. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Int Angiol 1998; 17: 135-45.
29. Kraemmer-Nielsen H. Pathophysiology of venous thromboembolism. Semin Thromb Hemost 1991; 17: 250-3.
30. Krünes U, Holzapfel R. Diagnostik der Unterschenkelvenenthrombose mit der Kompressionssonographie. Phlebologie 1998; 27: 39-42.
31. Lindahl TL, Lundahl TH, Nilsson L et al. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee - a prospective study. Thromb Haemost 1999; 81: 18-21.
32. Marshall M. Sonographische Diagnostik der tiefen Beinvenenthrombose. Phlebologie 2004; 33: 125-7.
33. Meissner MH, Caps MT, Zierler BK et al. Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg 1998, 28: 826-33.
34. Michiels JJ, Schroyens W, De Backer W et al. Non-invasive exclusion and diagnosis of pulmonary embolism by sequential use of the rapid ELISA D-dimer assay, clnical score and spiral CT. Int Angiol 2003; 22: 1-14.
35. Nordström M, Lindblad B, Anderson H et al. Deep venous thrombosis and occult malignancy: an epidemiological study. Br Med J 1994; 308: 891-4.
36. Nordström M, Lindblad B, Bergqvist D et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban populations. J Intern Med 1992, 232: 155-60.
37. Planes A, Vochelle NV. Venous stasis and trauma in hip surgery. In: Bergquist D, Comerota AJ, Nicolaides AN et al. (eds). Prevention of Venous Thromboembolism. London: MED-ORION 1994: 57-62.
38. Poort SR, Rosendaal FR, Reitsma PH et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
39. Prandoni P, Lensing AWA, Büller HR et al. Deep vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-33.
40. Roumen-Klappe EM, den Heijer M, Janssen MCH et al. The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six years follow-up study. J Thromb Haemost 2004 (in press).
41. Schellong SM, Schwarz T, Halbritter K et al. Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrmobosis. Thromb Haemost 2003: 89: 228.
42. Sevitt A. The structure and growth of valve-pocket thrombi in femoral veins. Clin Pathol 1974; 27: 517-28.
43. Sharrock NE, Go G, Harpel PC et al. The John Charaley Award. Thrombogenesis during total hip arthroplasty. Clin Orthop 1995; 319: 16-27.
44. Simioni P, Sanson B-J, Prandoni P et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999; 81: 198-202.
45. Stewart GJ, Alburger PD, Stone EA et al. Total hip replacement induces injury to remote veins in a canine model. J Bone Joint Surg 1983; 65(A): 97-102.
46. Stewart GJ, Lachmann JW, Alburger PD et al. Intraoperative venous dilation and subsequent development of deep vein thrombosis in patients undergoing total hip or total knee replacement. Ultrasound Med Biol 1990; 16: 133-40.
47. Stewart GJ, Ziskin MC, Schaub RG et al. Use of ultrasound for noninvasive study of blood vessel responsiveness. Am J Physiol 1987; 253: 671-9.
48. Tatò E. Diagnostische Strategien für die venöse Thromboembolie. Phlebologie 2002; 31: 150-5.
49. Thomas DP. Overview of venous thrombogenesis. Semin Thromb Hemost 1988; 14: 1-8.
50. Van den Oever R, Hepp B, Debbaut B et al. Socio-economic impact of chronic venous insufficiency. AB underestimated public health problem. Int Angiol 1998, 17: 161-7.
51. Vandenbroucke JP, Koster T, Briet E et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344, 1453-6.
52. Weichert W, Breddin HK, Staubesand J. Application of a laser-induced endothelial injury model in the screening of antithrombotic drugs. Semin Thromb Hemost 1988; 14: 106-14.
53. Weichert W, Breddin HK. Effect of low molecular weight heparins on laser-induced thrombus formation in rat mesenteric vessels. Haemostasis 1988; 18: 55-63.
54. Weidmann B, Jansen W, Franzen B et al. Ergebnisse der systemischen Lysetherapie mit ultrahoch dosierter Streptokinase bei tiefen Beinvenenthrombosen. Phlebologie 2001; 30: 16-20.
55. Wessler S, Reimer SM, Sheps MC. Biologic assay of a thrombosis-inducing activity in human serum. J Appl Physiol 1959; 14: 943-6.